netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Search
 Formulary Chapter 24: Leeds Children's Hospital Formulary - Full Chapter
Notes:

The Leeds Children's Hospital Formulary is laid out in BNF chapter order. There are custom indexes for the following specialist areas:

Paediatric Intensive Care Unit (PICU)
Neonatal Intensive Care Unit (NICU)
Paediatric Cardiology

Chapter Links...
 Details...
24.17  Expand sub section  Miscellaneous (paediatric)
**PICU (paediatric ICU) IV compatibility chart
(paediatrics)
Formulary
  • For use on LTHT Paediatric ICU only
 
Link  PICU IV compatibility chart (LTHT PICU use only)
   
Acetylcysteine (IV)
(paediatrics)
View SPC online View childrens BNF
Formulary  
Link  PICU prescribing and administration guide (acetylcysteine)
Link  BNFc paracetamol poisoning dosing information
Link  Management of children with paracetamol overdose (guideline) (NHS access only)
   
Atenolol (haemangioma)
(paediatric medicine)
View SPC online View childrens BNF
Restricted Drug Restricted
Amber 2
  • NHS Leeds Traffic Light List classification (link): AMBER 2 for the management of infantile haemangiomas 
  •    
    Bicavera (peritoneal dialysis)
    (paediatrics)
    View SPC online View childrens BNF
    Formulary  
    Link  LTHT Peritoneal Dialysis prescription chart
    Link  LTHT: PICU peritoneal dialysis guideline
       
    Factor Concentrate
    (paediatrics)
    View SPC online View childrens BNF
    Formulary  
    Link  LTHT prescription chart - factor concentrate (paediatric)
       
    Levamisole (unlicensed medicine)
    (paediatrics)
    View SPC online View childrens BNF
    Formulary
    Amber 3
  • For the management of nephrotic syndrome
     
  • Link  Amber Drug Guidance: steroid sensitive nephrotic syndrome in children
    Link  Levamisole regional guidelines
       
    Metabolic Formulary
    (paediatrics)
    View SPC online View childrens BNF
    Formulary
    Multiple

    See links below for further information on available products and prescribing guidance

    Amber2 - Drugs used in inherited metabolic disorders

    • ammonium tetrathiomolybdate
    • arginine
    • betaine
    • biotin
    • calcium folinate (folinic acid)
    • carbamylglutamate
    • carnitine
    • chenodeoxycholic acid
    • citrulline
    • co-careldopa
    • copper histidine
    • dextromethorphan
    • dichloroacetate
    • glycerol phenylbutyrate
    • glycine
    • hydroxocobalamin
    • 5-hydroxytryptophan
    • NTBC (nitisinone)
    • pyridoxal phosphate
    • pyridoxine
    • riboflavin
    • sodium benzoate
    • sodium phenylbutyrate
    • tetrahydrobiopterin
    • thiamine
    • trientine dihydrochloride
    • l-tryptophan
    • ubidecarenon/ubiquinone (co-enzyme Q10)
    • vitamin C (ascorbic acid)
    • zinc sulphate

    Amber1 -Dietary products used in metabolic disorders ; includes the following products:

    • Anamix
    • Basecal 100 and 200
    • Complete amino acid mix
    • Dialamine
    • DHH/AA module
    • Docomega
    • EAA supplement
    • Energivit
    • Essential amino acid mix
    • Galactomin 19
    • GA1 Anamix
    • Glycosade
    • Glytactin
    • Key Omega
    • Monogen
    • MSUD Anamix
    • PKU Anamix
    • TYR Anamix
    • UCD Amino 5

     

     
    Link  Drugs used in inherited metabolic disorders
    Link  Amber Drug Guidance: Paediatric Levocarnitine Solution for the Treatment of Carnitine Deficiency
    Link  British Inherited Metabolic Disease Group - guidelines for prescribers
    Link  Dietary products used in metabolic disorders
    Link  The National Society for Phenylketonuria: prescribing low protein foods in PKU
       
    Palliative Care Formulary
    (paediatrics)
    View SPC online View childrens BNF
    Formulary
  • The APPM Master Formulary is followed by Martin House
  • Also follow local policies and guidelines 
  • Link  APPM Master Formulary (click ’guidelines and resources’)
    Link  Paediatric End of Life Care Guideline (includes symptom management flow sheets)
       
    Propranolol (haemangioma)
    (paediatrics)
    View SPC online View childrens BNF
    Formulary  
    Link  Initiation of Propranolol in children with haemangioma
    Link  Propranolol for haemangioma in children - Patient/Carer information leaflet (PIL) (LTHT only)
       
    Timolol 0.5% long acting eye drops (topical treatment of haemangioma)
    (paediatrics)
    View SPC online View childrens BNF
    Restricted Drug Restricted
    Red
  • Unlicensed use of a licensed product 
  • Link  Drug and Therapeutics Group summary - July 2013
       
    Trientine Dihydrochloride
    (paediatrics)
    View adult BNF View SPC online View childrens BNF
    Formulary
    Red
     
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to children's BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Green

    Medicines which are appropriate for initiation and ongoing prescribing in both primary and secondary care.  

    Amber 1

    Amber Level 1- Specialist Recommendation
    These medicines are considered suitable for GP prescribing following specialist recommendation.
     
    There is no requirement for full Amber Drug Guidance. Generic Amber Level 1 Drug Guidance detailing responsibilities and information sources is available here
      

    Amber 2

    Amber Level 2- Specialist Initiation but no monitoring requirements
    These medicines are considered suitable for GP prescribing following specialist initiation, including titration of dose and assessment of efficacy.
    Some Amber Level 2 products will have an associated Amber Level 2 Drug Guidance document, available by clicking on the traffic light symbol to the right of the drug name. If this is not available, generic Amber Level 2 Drug Guidance is available here  

    Amber 3

    Amber Level 3- Specialist Initiation with ongoing monitoring requirements (Full Amber Drug Guidance required)
    Medicines that should be initiated by a specialist, and which require significant monitoring on an ongoing basis. Full agreement to share the care of each specific patient must be reached under the amber drug agreement, and Amber Drug Guidance must be provided to the GP (available by clicking on the traffic light symbol to the right of the drug name).   

    Red

    Guidance on the responsibilities for Red Drugs can be found here. Red Drugs would usually by prescribed by the hospital for the duration of the course. Primary care prescriber initiation or continuation of treatment not recommended except by Specialist GP and community paediatric prescribing.   

    Grey

    Grey Drugs are locally-agreed medicines which are only recommended for restricted use within the Leeds Health Economy.   

    Black

    These drugs are not recommended for use within the Leeds Health Economy  

    Multiple

    Products shown as blue have different Traffic Light List classifications dependent on indication. See the accompanying text next to the product for further information the indications for which it has a Traffic Light List classification.  

    netFormulary